Jiawei Foshou San Induces Apoptosis in Ectopic Endometrium Based on Systems Pharmacology, Molecular Docking, and Experimental Evidence
article
OA: gold
CC0
⤵ 7 in-corpus citations
AI-generated summary
Jiawei Foshou San reduced ectopic endometrium size by suppressing E2 and PROG, activating apoptosis through the Bcl-2 pathway and increasing caspase-3 and caspase-9 expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Foshou San is a typical gynaecological formula with wild usage in traditional Chinese medicine. Jiawei Foshou San (JFS) is a novel ingredient prescription from Foshou San with antiendometriosis effect in unclear mechanisms. To uncover the potential application and proapoptotic mechanisms of JFS, JFS ingredient-drug target-disease networks, GO enrichment, and pathway analysis were established for potential application prediction. Molecular docking and validation in vivo were investigated by the proapoptotic mechanisms of JFS. In this study, 99 common targets were related to 108 diseases. 484 biological processes, 44 cell components, 59 molecular functions, and 37 pathways were significantly identified in GO enrichment and pathway analysis. In molecular docking, ligustrazine showed binding activity with Bcl-2, Bax, caspase-9, caspase-3, and PARP. In vivo, JFS elevated the shrink rate of ectopic endometrium, by suppressing E2 and PROG. An in-depth study showed that apoptosis was activated through diminishing Bcl-2, rising Bax and Bad, and expressing more caspase-3 and caspase-9 using JFS. JFS promoted the protein level of cleaved-PARP. In brief, JFS might be applied for various diseases through multiple targets and pathways, especially endometriosis by Bcl-2 pathway. These findings reveal the potential application for further evaluation and uncover the proapoptotic mechanism of JFS.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Anti-endometriosis Mechanism of Jiawei Foshou San Based on Network Pharmacology via openalex
- Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β<sub>2</sub> via openalex
- Combination use of ferulic acid, ligustrazine and tetrahydropalmatine inhibits the growth of ectopic endometrial tissue: A multi-target therapy for endometriosis rats via openalex
- Effect of alpha‐lipoic acid on endometrial implants in an experimental rat model via openalex
- Endometriosis-associated malignant transformation in abdominal surgical scar via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Endometriosis: The Ultimate Hormonal Disease via openalex
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis via openalex
- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
- Plant-derived medicines for treatment of endometriosis: A comprehensive review of molecular mechanisms via openalex
- Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis. via openalex
- Social psychogenic stress promotes the development of endometriosis in mouse via openalex
- The Apoptotic, Angiogenic and Cell Proliferation Genes CD63, S100A6 e GNB2L1 are Altered in Patients with Endometriosis via openalex
- Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via openalex
- W2258963753 via openalex
- W2279201083 via openalex
- W2292603158 via openalex
- W2511018985 via openalex
- W2519654355 via openalex
- W2554509393 via openalex
- W2588489463 via openalex
- W2766323989 via openalex
- W2772400483 via openalex
- W2800735024 via openalex
- W2803349141 via openalex
- W2806744486 via openalex
- W2809908634 via openalex
- W2898277486 via openalex
- W2904251403 via openalex
- W2912119023 via openalex
- W2917075888 via openalex
- W2920891384 via openalex
- W2933156802 via openalex
- W2936680575 via openalex
- W1498409973 via openalex
- W3022749755 via openalex
- W1577462076 via openalex
- W1592450899 via openalex
- W1898775545 via openalex
- W1966052797 via openalex
- W1994054982 via openalex
- W2002808160 via openalex
- W2010852194 via openalex
- W2029335938 via openalex
- W2043950247 via openalex
- W2059151656 via openalex
- W2094085336 via openalex
- W2095612053 via openalex
- W2095754263 via openalex
Cited by (7)
- Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 2025
- Exploring the Treatment of Classic Prescriptions Based on the Traditional Chinese Medicine Inheritance Assistance Platform Medication Patterns for Endometriosis 2025
- Research Progress of Caspase in Endometriosis 2024
- Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases 2023
- Tetramethylpyrazine Stalls Lesional Progression via Inducing Senescence in Mouse with Induced Deep Endometriosis 2022
- Combination of ferulic acid, ligustrazine and tetrahydropalmatine inhibits invasion and metastasis through MMP/TIMP signaling in endometriosis 2021
- Combination of Ferulic Acid, Ligustrazine and Tetrahydropalmatine attenuates Epithelial-mesenchymal Transformation <i>via</i> Wnt/β-catenin Pathway in Endometriosis 2021
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:22:22.912744+00:00
License: CC0
· commercial use OK